Midazolam belongs to which drug class?

Prepare for emergency medicine exams with our comprehensive test. Explore multiple choice questions, receive hints and explanations. Sharpen your knowledge and ensure success!

Multiple Choice

Midazolam belongs to which drug class?

Explanation:
Midazolam is a benzodiazepine, a class of sedatives that enhance the inhibitory effect of GABA in the brain. It binds to the benzodiazepine site on the GABA-A receptor and acts as a positive allosteric modulator, increasing the likelihood that the chloride channel opens when GABA binds. This boosts neuronal inhibition, producing rapid sedation, anxiolysis, and anterograde amnesia with a relatively short duration—features that make it especially useful for procedural sedation and short-term anesthesia in emergency settings. This mechanism and clinical profile differentiate midazolam from barbiturates, which also affect GABA-A but by a different action (often increasing the duration of chloride channel opening) and generally carry a higher risk of respiratory depression and longer-lasting effects. It also differs from anticholinergics, which block acetylcholine receptors and cause delirium or dry secretions, and from opioids, which provide analgesia and can depress respiration through separate pathways.

Midazolam is a benzodiazepine, a class of sedatives that enhance the inhibitory effect of GABA in the brain. It binds to the benzodiazepine site on the GABA-A receptor and acts as a positive allosteric modulator, increasing the likelihood that the chloride channel opens when GABA binds. This boosts neuronal inhibition, producing rapid sedation, anxiolysis, and anterograde amnesia with a relatively short duration—features that make it especially useful for procedural sedation and short-term anesthesia in emergency settings.

This mechanism and clinical profile differentiate midazolam from barbiturates, which also affect GABA-A but by a different action (often increasing the duration of chloride channel opening) and generally carry a higher risk of respiratory depression and longer-lasting effects. It also differs from anticholinergics, which block acetylcholine receptors and cause delirium or dry secretions, and from opioids, which provide analgesia and can depress respiration through separate pathways.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy